|Title:|| Treatment of idiopathic thrombocytopaenic purpura|
|Abstract:||A method of treating idiopathic thrombocytopaenia purpura with 2',3'-dideoxy-3'-azidonucleosides, in particular 3'-azido-3'-deoxythymidine, is disclosed.|
|Inventor(s):|| Kirk, III; Leone E. (Raleigh, NC), King; Dannie H. (Raleigh, NC), Clemons; Richard H. (Cary, NC), Lehrman; Sandra N. (Durham, NC), Barry; David W. (Chapel Hill, NC) |
|Assignee:|| Burroughs Wellcome Co. (Research Triangle Park, NC) |
|Filing Date:||Apr 02, 1991|
|Claims:||1. A method of treating idiopathic thrombocytopaenia purpura in a human in need thereof, which comprises administering to said human an effective thrombocytopaenia purpura treatment amount of a compound 3'-azido-3'-deoxythmidine. |
2. The method of claim 1, in which said compound is administered orally.
3. The method of claim 1, in which said compound is administered parenterally.
4. The method of treating a patient diagnosed as having thrombocytopaenia purpura, which comprises orally or intravenously administering an effective thromocytopaenia purpura treatment amount of 3'-azido-3'-deoxythymidine to said patient.
5. A method of increasing platelets in a patient in need thereof, which comprises administering an effective platelet increasing amount of 3'-azido-3'-deoxythymidine to said patient.